Hubei Provincial Party Secretary Wang Zhonglin emphasized the need to accelerate the construction of an internationally competitive "Chinese Medicine Valley" during his research on the development of the biopharmaceutical and high-end medical equipment industries in Wuhan.

According to the website of the People's Government of Wuhan City, on August 4th, Wang Zhonglin, Secretary of the Hubei Provincial Party Committee and Director of the Standing Committee of the Provincial People's Congress, conducted research on the development of the biopharmaceutical and high-end medical equipment industries in Wuhan Donghu New Technology Development Zone. He emphasized the need to adhere to facing the world's technological frontier, facing the main economic battlefield, facing the major national needs, and facing the health and life of the people, to further promote original and leading scientific research and development, strengthen promotion and application, optimize the development environment, expand and strengthen the biopharmaceutical and high-end medical equipment industry clusters, and accelerate the construction of a "Chinese Medicine Valley" with international competitiveness. During the research, Wang Zhonglin emphasized that the biopharmaceutical and high-end medical equipment industries are strategic emerging industries related to the national economy and people's livelihood, leading industries in development, with broad prospects and great potential. It is necessary to pay great attention to and seize opportunities, exert greater efforts in strengthening leading enterprises, filling gaps in the industry chain, and gathering clusters, to accelerate the deep integration of scientific and industrial innovation, and foster and strengthen new productive forces in the field of medical and health care. It is necessary to promote the deep integration of clinical needs and industrial development, adhere to inclusive and prudent supervision, promote the research, promotion, and application of new technologies and products. It is necessary to strengthen the guarantee of elements such as funds and land, better play the role of industrial investment funds in guiding, and drive more social capital to "invest early, invest small, and invest in hard technology." It is necessary to improve service quality and efficiency, provide full-chain, full-life cycle services for the innovative growth of enterprises, and create a good ecological environment for the development of the biopharmaceutical and high-end medical equipment industries.